基于托里帕利马布的化疗免疫疗法用于大鼻的不可切除的鼻腔NUT癌症:一个病例报告
Dan Yu1,2, Ling Lin1,2, Jian Tan1
1Department of Otorhinolaryngology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Frontiers in immunology
|March 12, 2026
概括
这项研究呈现了一种无法切除的上鼻癌 (NUT) 的病例,该病例使用基于toripalimab的化疗免疫疗法治疗. 治疗实现了早期的部分反应,为管理这种罕见的癌症提供了希望.
科学领域:
- 在瘤学瘤学.
- 罕见的癌症 罕见的癌症
- 免疫治疗是一种免疫疗法.
背景情况:
- 丸中核蛋白 (NUT) 癌症是一种罕见的,侵袭性的恶性瘤,经常表现出模糊的症状.
- 鼻卷入是不常见的,导致诊断延迟和糟糕的结果,如果不可切除.
研究的目的:
- 报告第一个基于toripalimab的化学免疫疗法用于不可切除的尾鼻癌NUT的病例.
- 评估这种新型治疗方法的疗效和安全性.
主要方法:
- 一名31岁的男性患有无法切除的上鼻癌 (NUT) 接受了toripalimab与多塞塔克塞尔和西斯普拉丁联合治疗.
- 通过MRI和PET-CT评估反应,并进行持续的维持治疗.
主要成果:
- 在三轮化疗免疫治疗后观察到早期放射性改善和部分反应.
- 瘤回归继续,在5个月的随访中,病残病稳定.
- 患者能很好地忍受治疗,并进行持续的维持疗法.
结论:
- 基于托里帕利马布的化疗免疫疗法在不可切除的尾鼻癌NUT中表现出早期疗效.
- PD-1阻塞与-纳化疗相结合可能是对鼻NUT癌症的可行策略.
更多相关视频
07:00Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
6.4K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
11.1K
相关概念视频
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K